Brandão, L.B. et al. 2025. The Evolution of Lymphangioleiomyomatosis (LAM) Management: From Hormonal Manipulation to Targeted Inhibition of the mammalian target of rapamycin (mTOR) Pathway. Research, Society and Development. 14, 4 (Apr. 2025), e4614448656. DOI:https://doi.org/10.33448/rsd-v14i4.48656.